Literature DB >> 27988896

Jim Crow and estrogen-receptor-negative breast cancer: US-born black and white non-Hispanic women, 1992-2012.

Nancy Krieger1, Jaquelyn L Jahn2, Pamela D Waterman2.   

Abstract

PURPOSE: It is unknown whether Jim Crow-i.e., legal racial discrimination practiced by 21 US states and the District of Columbia and outlawed by the US Civil Rights Act in 1964-affects US cancer outcomes. We hypothesized that Jim Crow birthplace would be associated with higher risk of estrogen-receptor-negative (ER-) breast tumors among US black, but not white, women and also a higher black versus white risk for ER- tumors.
METHODS: We analyzed data from the SEER 13 registry group (excluding Alaska) for 47,157 US-born black non-Hispanic and 348,514 US-born white non-Hispanic women, aged 25-84 inclusive, diagnosed with primary invasive breast cancer between 1 January 1992 and 31 December 2012.
RESULTS: Jim Crow birthplace was associated with increased odds of ER- breast cancer only among the black, not white women, with the effect strongest for women born before 1965. Among black women, the odds ratio (OR) for an ER- tumor, comparing women born in a Jim Crow versus not Jim Crow state, equaled 1.09 (95% confidence interval [CI] 1.06, 1.13), on par with the OR comparing women in the worst versus best census tract socioeconomic quintiles (1.15; 95% CI 1.07, 1.23). The black versus white OR for ER- was higher among women born in Jim Crow versus non-Jim Crow states (1.41 [95% CI 1.13, 1.46] vs. 1.27 [95% CI 1.24, 1.31]).
CONCLUSIONS: The unique Jim Crow effect for US black women for breast cancer ER status underscores why analysis of racial/ethnic inequities must be historically contextualized.

Entities:  

Keywords:  Black Americans; Breast cancer estrogen receptor; Health inequities; Jim Crow; Racial disparities; Segregation

Mesh:

Substances:

Year:  2016        PMID: 27988896     DOI: 10.1007/s10552-016-0834-2

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  27 in total

1.  Beyond Obesity: The Rising Incidence and Mortality Rates of Uterine Corpus Cancer.

Authors:  Megan A Mullins; Michele L Cote
Journal:  J Clin Oncol       Date:  2019-06-20       Impact factor: 44.544

2.  Racial Discrimination in Health Care and Utilization of Health Care: a Cross-sectional Study of California Adults.

Authors:  Héctor E Alcalá; Daniel M Cook
Journal:  J Gen Intern Med       Date:  2018-08-08       Impact factor: 5.128

3.  Modified Radical Mastectomy in De Novo Stage IV Inflammatory Breast Cancer.

Authors:  J C Chen; Yaming Li; James L Fisher; Oindrila Bhattacharyya; Allan Tsung; Jose G Bazan; Samilia Obeng-Gyasi
Journal:  Ann Surg Oncol       Date:  2022-06-08       Impact factor: 4.339

4.  Response to Krieger.

Authors:  Brittny C Davis Lynn; Pavel Chernyavskiy; Gretchen L Gierach; Philip S Rosenberg
Journal:  J Natl Cancer Inst       Date:  2022-09-09       Impact factor: 11.816

5.  RE: Decreasing Incidence of Estrogen Receptor-Negative Breast Cancer in the United States: Trends by Race and Region.

Authors:  Nancy Krieger
Journal:  J Natl Cancer Inst       Date:  2022-09-09       Impact factor: 11.816

6.  Association Between Residence in Historically Redlined Districts Indicative of Structural Racism and Racial and Ethnic Disparities in Breast Cancer Outcomes.

Authors:  Jesse J Plascak; Kirsten Beyer; Xinyi Xu; Antoinette M Stroup; Gabrielle Jacob; Adana A M Llanos
Journal:  JAMA Netw Open       Date:  2022-07-01

7.  A Qualitative Analysis of How Anthropologists Interpret the Race Construct.

Authors:  Jayne O Ifekwunigwe; Jennifer K Wagner; Joon-Ho Yu; Tanya M Harrell; Michael J Bamshad; Charmaine D Royal
Journal:  Am Anthropol       Date:  2017-08-14

8.  Essentialism and Exclusion: Racism in Cancer Risk Prediction Models.

Authors:  Erika A Waters; Graham A Colditz; Kia L Davis
Journal:  J Natl Cancer Inst       Date:  2021-04-26       Impact factor: 13.506

9.  Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.

Authors:  Alexander P Cole; Peter Herzog; Hari S Iyer; Maya Marchese; Brandon A Mahal; Stuart R Lipsitz; Joshua Nyambose; Susan T Gershman; Mark Kennedy; Gail Merriam; Timothy R Rebbeck; Quoc-Dien Trinh
Journal:  Cancer       Date:  2021-05-17       Impact factor: 6.921

10.  Developing a Database of Structural Racism-Related State Laws for Health Equity Research and Practice in the United States.

Authors:  Madina Agénor; Carly Perkins; Catherine Stamoulis; Rahsaan D Hall; Mihail Samnaliev; Stephanie Berland; S Bryn Austin
Journal:  Public Health Rep       Date:  2021-02-22       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.